Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia
Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia
About this item
Full title
Author / Creator
Liu, C , Kawedia, J D , Cheng, C , Pei, D , Fernandez, C A , Cai, X , Crews, K R , Kaste, S C , Panetta, J C , Bowman, W P , Jeha, S , Sandlund, J T , Evans, W E , Pui, C-H and Relling, M V
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Hypersensitivity to asparaginase is common, but the differential diagnosis can be challenging and the diagnostic utility of antibody tests is unclear. We studied allergic reactions and serum antibodies to
E. coli
asparaginase (Elspar) in 410 children treated on St. Jude Total XV protocol for acute lymphoblastic leukemia. Of 169 patients (41.2...
Alternative Titles
Full title
Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3516853
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3516853
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/leu.2012.102
